Leishmaniasis D007896

Related MeSH Hierarchy (4)

Diseases [C] » Infections [C01] » Parasitic Diseases » Protozoan Infections » Euglenozoa Infections » Leishmaniasis

Diseases [C] » Infections [C01] » Parasitic Diseases » Skin Diseases, Parasitic » Leishmaniasis

Diseases [C] » Infections [C01] » Vector Borne Diseases » Leishmaniasis

Description

A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).   MeSH

Subtype Terms (2)

Leishmaniasis, Cutaneous
33 drugs (15 approved, 18 experimental)

Leishmaniasis, Visceral
21 drugs (10 approved, 11 experimental)


Phase 1 Indicated Drugs (5)


Organization Involved with Phase 3 Indications (53)

Organization Involved with Phase 1 Indications (4)

Organization Involved with Other Experimental Indications (4)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.